January 23, 2026 · Form 4 insider transaction
Milne Jill C. bought 26,684 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.; The option grant vests 1/36 per month over a 3-year period measured from the date of grant.